Idiopathic Pulmonary Fibrosis Header Gradient Overlay - BLUE Return to the Respiratory homepage IDIOPATHIC PULMONARY FIBROSIS TRIALS Idiopathic Pulmonary Fibrosis Integrated solution to measure lung function endpoints like FVC and DLCO.

How will you mitigate the risk in IPF drug development?

In idiopathic pulmonary fibrosis (IPF), a chronic and progressive restrictive lung disease, a decline in forced vital capacity (FVC) is used as a primary endpoint in clinical trial. As IPF is a restrictive lung disease, lung diffusion measurements like DLCO and TLCO are needed to monitor drug efficacy. The importance of accurate data collection is critical to demonstrating drug effectiveness in clinical trial.




ACHIEVE THE HIGHEST DATA QUALITY AND REDUCE VARIABILITY

ERT has partnered with sponsors in over 1000 drug development studies. Our lung function testing devices, workflow-driven software, and quality services ensure your trial’s spirometry quality and overall site performance and mitigates the risks in IPF drug development. ERT offers an integrated solution to measure lung function endpoints, using integrated devices and software to measure FVC.

Experts in Respiratory Solutions


3 Strategies to Capture Respiratory Data

e-Book

3 Strategies to Capture Respiratory Data

This quick guide gives you strategies and tips you need to collect high-quality data and get compounds to market faster.


LEARN MORE ABOUT HOW ERT CAN SUPPORT YOUR CLINICAL TRIAL with an integrated solution


FEV1

(Forced Expiratory Volume at one second) is a strong indicator of future exacerbation in asthma patients.

SITE SUPPORT:

HOME SUPPORT:

FVC

(Forced Vital Capacity) provides information about the level of airflow restriction in patients.

SITE SUPPORT:

HOME SUPPORT:

LCI

(Lung Clearance Index) measured by multiple breath washout is a sensitive measure of ventilation inhomogeneity.

SUPPORTED DEVICES

肺拡散能(DLCO)

(Diffusing Capacity for CO) measures the lung’s ability to transfer gas from inhaled air to the red blood cells.

SUPPORTED DEVICES

eCOA

Collects respiratory patient questionnaires for real-time insights into patient safety and study performance.

Learn More

心臓安全性中央解析

Captures, reads, and stores ECGs centrally to avoid the risk of false or inaccurate data.

Learn More

イメージング

Measures and analyzes imaging endpoints like chest computed tomography (CT) to provide on-demand evidence of drug safety and efficacy.

Learn More

ASTHMA Trials

Asthma Trials

Capture pulmonary function test data along with symptoms of asthma exacerbations, like breathlessness, chest pain, cough, and wheezing to help improve patients’ quality of life. ERT’s integrated solution will ensure you are collecting acceptable data for your study’s regulatory submissions.

詳細を見る

COPD Trials

COPD Trials

Demonstrate your Chronic Obstructive Pulmonary Disease (COPD) study’s efficacy in improving lung function and quality of life symptoms with improved data acceptability and exacerbation event capture. ERT’s respiratory solution helps you meet your study goals.

詳細を見る

Cystic Fibrosis Trials

Cystic Fibrosis Trials

Identify the right endpoints for your complex cystic fibrosis (CF) trials. ERT has solutions that measure multiple lung function parameters and can be integrated with other endpoint measurement data solutions.

詳細を見る


Disease Progression Trials

Lung Safety and Disease Progression Trials

Because decline in respiratory function is a direct result of progression of certain non-pulmonary diseases, demonstrating a treatment benefit on respiratory endpoints may provide evidence of your drug’s effectiveness. ERT enables precise lung function testing integrated with other efficacy data points like patient-reported outcomes (PRO) and more.

詳細を見る

自宅で行う肺活量測定

自宅で行う肺活量測定

Spirometry collection at home, by patient, or with home nurse integrates with other ERT at-home solutions to keep patients safe and studies on track.

詳細を見る

参考資料

Slide COPD Trials

Data Sheet

Quality/Outlier Report

Attain actionable insights to increase study power and reduce variability

詳細
Slide Respiratory-Spirosphere

Data Sheet

SpiroSphere®

Take your spirometry to the next level with our smart, portable, and affordable spirometer.

詳細
Slide Other indications that impair respiratory muscles and include pulmonary function testing to monitor disease progression

Data Sheet

MasterScope

Minimize risk and uncertainty with our centralized spirometry, ECG, patient -reported outcomes and multi-endpoint platform.

詳細
Slide

Data Sheet

LCI

Obtain Lung Clearance Index to detect disease progression of early lung disease more accurately.

詳細
Slide Clinician observes the patient’s function and feeling and completes an electronic assessment (eClinRO) to be submitted in support of the clinical trial’s endpoints

Data Sheet

肺拡散能(DLCO)

Centralize your DLCO data collection and analysis to ensure data quality in your clinical trial.

詳細
Slide Other indications that impair respiratory muscles and include pulmonary function testing to monitor disease progression

Data Sheet

AM3

詳細

Make home monitoring easy with our integrated home spirometer and electronic diary.

Slide

Data Sheet

iSpiro®

A home spirometry sensor in conjunction with the iSpiro App collects full spirometry at home.

詳細

専門家に相談


Our team of experts is available to address questions you may have about our integrated respiratory solutions.
フォームのご記入後に、専門の担当者よりご連絡差し上げます。